Skip to content
Enough Ventures

Work / Xelios

Xelios: lab automation for advanced cell workflows.

Xelios is a company in formation. It aims to make advanced cell-lab work easier to repeat and to control, using robotics, AI, image-based quality checks and structured run data. It starts with research use only: work in research labs, not in clinics or diagnosis.

Where it stands

Three pieces of work are under way. Together they will show whether the evidence supports forming the company.

Xelios is not offered as a clinical, diagnostic or commercial product, and it is not generally available.

As of November 2026.

Company formation
Whether the evidence supports a new company.In progress
Conversations with labs
Whether labs see this problem and would take part in a pilot.Under way
Research-use pilot
What the first pilot covers and how its results would be judged.Being defined

What is being tested now

  • First workflow

    Research-use automation for advanced cell-lab work where reproducibility and workflow control matter.

  • Technical assumptions

    Image-based quality checks, structured run data and robotic workflow control are under test.

  • Commercial proof

    Buyer conversations and pilot scoping test whether this workflow can support a company.

Want to know more about Xelios?

We share more detail in private conversations where there is a clear reason to.